Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men-Reference-Cited by-同舟云学术

Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men

Published:2017-03 Issue:2 Volume:78 Page:232-240
ISSN:1937-1888
Container-title:Journal of Studies on Alcohol and Drugs
language:en
Short-container-title:J. Stud. Alcohol Drugs

Author:

Isgro Melodie¹²,Doran Neal²,Heffner Jaimee L.³,Wong Esther²,Dinh Elizabeth²,Tibbs Jessie¹,Russell Katie¹²,Bittner Tracy²,Wehrle Chris²,Worley Matthew J.¹²,Anthenelli Robert M.¹²

Affiliation:

1. Pacific Treatment and Research Center (Pac-TARC), San Diego VeteransAffairs Healthcare System, San Diego, California

2. Department of Psychiatry, University of California, San Diego, Health Sciences, La Jolla, California

3. Fred Hutchinson Cancer Research Center, Seattle, Washington

Publisher

Alcohol Research Documentation, Inc.

Subject

Psychiatry and Mental health,Toxicology,Health (social science)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder;Alcoholism: Clinical and Experimental Research;2022-01-31

2. Topiramate for smoking cessation: Systematic review and meta-analysis;Tobacco Prevention & Cessation;2020-02-24

3. Therapeutische Strategien bei Alkohol- und Tabakabhängigkeit;Alkohol und Tabak;2020

4. Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review;Journal of Addiction Medicine;2019-01

5. Predictors of reduced smoking quantity among recovering alcohol dependent men in a smoking cessation trial;Addictive Behaviors;2018-09